1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsCollaborative Research Development Grant – AI is sponsored by Ovarian Cancer Research Alliance (OCRA). This grant, in partnership with Microsoft's AI for Good Lab, aims to harness the power of data science and AI to accelerate ovarian cancer research. It encourages collaborations between AI researchers and cancer researchers.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Ovarian Cancer Research Grant Programs | OCRA Ovarian Cancer Research Grant Programs OCRA’s Schreiber Research Grants Program supports gifted scientists at every stage of their careers, including postdoctoral fellows, early-career independent investigators, and teams of experienced investigators.
Championing the Most Promising Research OCRA has awarded over 400 grants to top scientists at 100 leading medical centers around the world, enabling a series of discoveries that have accelerated our journey toward a cure. All of our grants involve a rigorous review process to ensure that only the most outstanding research projects are funded.
The Global Ovarian Cancer Research Consortium, comprising Ovarian Cancer Research Alliance (OCRA, USA), Ovarian Cancer Action (OCA, UK), Ovarian Cancer Canada (OCC), and The Ovarian Cancer Research Foundation (OCRF, Australia), provides a $1 million USD grant, along with AWS compute support, to power research that aims to improve ovarian cancer survival rates.
This grant was introduced in 2025 in partnership with Microsoft’s AI for Good Lab and now provides in-kind cloud compute credits from Amazon Web Services (AWS). This grant supports international, multidisciplinary research using artificial intelligence (AI) to improve ovarian cancer survival rates.
Proposals must include lead investigators from the United States, United Kingdom, Canada, and Australia, and must demonstrate significant AI integration. Support of up to $1 million USD to be used over 3 years, will be awarded to the institution of the Principal Investigator.
Collaborative Research Development Grant Launched in 2004, this grant provides funds for research projects focusing on ovarian cancer and/or related gynecologic cancer research, that involve several investigators within one institution or collaborations between groups in multiple institutions.
Support of $300,000 annually for three years, for a total of $900,000, will be awarded to the institution where the recipient will conduct the research. Collaborative Research Development Grant – Microsoft's AI for Good Lab Launched in 2022, this grant is the result of a unique partnership between OCRA and Microsoft’s AI for Good Lab, a philanthropic program at Microsoft.
This collaboration will help OCRA accelerate ovarian cancer and/or related gynecologic cancer research by harnessing the power of data science and Artificial Intelligence (AI), potentially leading to new insights into the disease.
The grant will provide funds for ovarian cancer and/or related gynecologic cancers research projects that may involve several investigators within one institution or collaborations between groups in multiple institutions. Support of $300,000 annually for three years, for a total of $900,000, will be awarded to the institution where the recipient will conduct the research in addition to in-kind support from Microsoft.
Early Career Investigator Grant The Early Career Investigator Grant (formerly the Liz Tilberis Early Career Award) is for junior faculty (Assistant Professor level) with a strong commitment to an investigative career in ovarian cancer and/or related gynecologic cancer research. Support of $150,000 annually for three years, for a total of $450,000, will be awarded to the institution where the recipients will conduct the research.
This grant was created in honor of Liz Tilberis, former editor-in-chief of Harper’s Bazaar and the first president of Ovarian Cancer Research Alliance, who passed away from ovarian cancer in 1999.
Mentored Investigator Grant The Mentored Investigator Grant (formerly the Ann and Sol Schreiber Mentored Investigator Award) provides funding for trainees (post-doctoral fellows or clinical fellows) working under the supervision of a mentor who is a recognized leader in ovarian cancer research, or related area. Applicants must have an MD or a PhD degree.
The grant provides a total of $100,000 to be used over one or two years and will encourage the recipient’s research career in the field of ovarian cancer and/or related gynecologic cancers. Ann Schreiber, a distinguished public administrator and wife of Ovarian Cancer Research Alliance’s founder Sol Schreiber, is the inspiration for this grant. Sol started OCRA in memory of Ann, who passed away from ovarian cancer in 1994.
Health Equity Research Grant OCRA’s first-ever Health Equity Research Grant (HEG) was launched in 2024. The first grant was sponsored by GSK. This grant is intended to overcome barriers to care faced by marginalized communities and is geared to all investigators with projects focusing on ovarian cancer and/or related gynecologic cancers research that have a health equity focus.
Support of $100,000 annually for two years, for a total of $200,000, will be awarded to the institution where the recipient will conduct the research. The Rivkin Pilot Grants pave the way for innovative breakthroughs in all areas of ovarian cancer research. Support of $50,000 annually for 2 years, totaling $100,000,* will be awarded to the institution where the recipient will conduct the research.
The grants were inspired by Marsha Rivkin, beloved wife of Dr. Saul Rivkin, a renowned oncologist at Swedish Hospital. After her death from ovarian cancer, Dr. Rivkin and his daughters established the Marsha Rivkin Ovarian Cancer Research Center, which eventually became the Seattle-based Rivkin Center. OCRA and the Rivkin Center joined forces in a historic collaboration in April 2025, enhancing OCRA’s national and global reach.
OCRA is proud to be continuing the Rivkin Center’s extraordinary legacy of hope, determination, and relentless pursuit of a cure through its Rivkin Pilot Grants. *Prior to 2027 funding cycle, this grant provided $75,000 over 2 years.
The Rivkin Center and Washington state’s Andy Hill Cancer Research Endowment (CARE) Fund joined together to invest $1M in ovarian cancer research in 2024 and 2025, creating a pioneering public-private partnership. Investigators in Washington state pursuing projects in all areas of ovarian cancer research were eligible to apply to these two-year awards.
Researchers did not need to find additional funding as the Rivkin Center and the CARE Fund matched private and state funds 1:1. Past Rivkin Center Grantees The Rivkin Center for Ovarian Cancer Research offered research grants from 1999 to 2025. In addition to the Rivkin Pilot Grant, which OCRA is continuing, Rivkin offered funds for 2 other grants: Scientific Scholar Awards and Bridge Funding Awards.
The Scientific Scholar Award was a two-year mentored career development grant of up to $120,000 for early researchers pursuing a career as an independent investigator. The Bridge Funding Award was a six-month grant for $30,000 which helped researchers gather the data needed to secure federal grants, allowing promising work to progress to the next stage.
Nearly 500 people have already registered for OCRA’s International Gynecologic Cancer Conference®—the largest conference dedicated to the gynecologic cancer community—taking place on September 16–17. The conference is free, online, and open to all, and will include programming for ovarian, endometrial, cervical, and rare gynecologic cancers. For the first time, each of these diseases will have a dedicated Ask the Experts session.
Learn … Continued Inside the Think Tank: Stopping Ovarian Cancer Before it Starts On June 1–2, the Ovarian Cancer Observatory—part of OCRA’s broader investment in research initiatives—convened its first in-person Forum in Vancouver. Roughly 50 of the field’s brightest clinicians, pathologists, and epidemiologists gathered for what became, in essence, a two-day think tank on preventing ovarian cancer.
The Observatory is funded through a grant from OCRA and was … Continued OCRA-Funded ROCCA Platform Launches to Accelerate Rare Ovarian Cancer Research OCRA is proud to announce the launch of the Rare Ovarian Cancer Collaborative Analytics (ROCCA) Platform, an international federated data network funded by OCRA to connect researchers globally and accelerate breakthroughs in rare ovarian cancer research.
A collaborative approach to research for rare ovarian cancer ROCCA is launching with two foundational projects: one in mucinous … Continued c. startsWith(this. consentName + '=')); this.
isVisible = ! this. hasConsent(); // 1 year expiry; SameSite=Lax + Secure for sane defaults.
const oneYear = 60 * 60 * 24 * 365; x-transition. opacity. duration.
300ms class="pointer-events-none fixed bottom-0 left-0 px-6 pb-6"
According to the current listing, eligibility includes: Non-profit entities, academia, and researchers. OCRA does not offer funding to for-profit entities, consulting companies, or non-profits not conducting the research themselves. Confirm the full requirements in the official notice before applying.
The current listing shows up to $900,000 over 3 years, plus in-kind support from Microsoft (Azure computing credits and data science support). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was September 15, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Collaborative Research Development Grant – AI is funded by Ovarian Cancer Research Alliance (OCRA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article